Overall, the study indicates that high levels of CXCR4 intracellular protein but not CXCR4 signaling restricts cellular apoptosis and promotes cell survival via downregulating the DR5 expression and thus renders cancer cells resistant to chemotherapeutic drugs like paclitaxel. This evidence concerns the gene CXCR4 and cancer.